These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 22174992)
1. Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial. Almirall P; Escobedo AA; Ayala I; Alfonso M; Salazar Y; Cañete R; Cimerman S; Galloso M; Olivero I; Robaina M; Tornés K J Parasitol Res; 2011; 2011():636857. PubMed ID: 22174992 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis. Escobedo AA; Cañete R; Gonzalez ME; Pareja A; Cimerman S; Almirall P Ann Trop Med Parasitol; 2003 Jul; 97(5):499-504. PubMed ID: 12930613 [TBL] [Abstract][Full Text] [Related]
3. Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. Canete R; Escobedo AA; Gonzalez ME; Almirall P World J Gastroenterol; 2006 Oct; 12(39):6366-70. PubMed ID: 17072963 [TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. Cañete R; Escobedo AA; González ME; Almirall P; Cantelar N Curr Med Res Opin; 2006 Nov; 22(11):2131-6. PubMed ID: 17076973 [TBL] [Abstract][Full Text] [Related]
5. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study. Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of mebendazole in paediatric patients with giardiasis: A systematic review and meta-analysis. Escobedo AA; Almirall P; González-Fraile E; Ballesteros J Acta Trop; 2018 Dec; 188():50-57. PubMed ID: 30092225 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Tolerability of 3-Day Mebendazole Treatment of Cañete R; Brito K; Brito I; Semper A; Gonzalez ME Curr Ther Res Clin Exp; 2018; 89():43-47. PubMed ID: 30792825 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Secnidazole Gel and Tinidazole Suspension in the Treatment of Giardiasis in Children. Cimerman B; Camilo Coura L ; C Salle JM ; Gurvitz R; Rocha RS; Bandeira S; Cimerman S; Katz N Braz J Infect Dis; 1997 Oct; 1(5):241-247. PubMed ID: 11105144 [TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series. Escobedo AA; Almirall P; Chirino E; Pacheco F; Duque A; Avila I Infez Med; 2018 Dec; 26(4):379-384. PubMed ID: 30555145 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial with Secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis. Di Prisco MC; Jiménez JC; Rodríguez N; Costa V; Villamizar J; Silvera A; Carrillo M; Lira C; Zerpa E; López Y Invest Clin; 2000 Sep; 41(3):179-88. PubMed ID: 11029834 [TBL] [Abstract][Full Text] [Related]
11. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Schwebke JR; Morgan FG; Koltun W; Nyirjesy P Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the therapeutic efficacy of Mentha crispa in the treatment of giardiasis. Teles NS; Fechine FV; Viana FA; Viana IO; Nascimento DF; Leite AL; Bezerra FA; Moraes MO; Moraes ME Contemp Clin Trials; 2011 Nov; 32(6):809-13. PubMed ID: 21872682 [TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children. Cañete R; Rivas DE; Escobedo AA; González ME; Almirall P; Brito K West Indian Med J; 2010 Dec; 59(6):607-11. PubMed ID: 21702232 [TBL] [Abstract][Full Text] [Related]
14. Comparative Study of the Efficacy and Tolerability of Secnidazole Suspension (single dose) and Tinidazole Suspension (two days dosage) in the Treatment of Amebiasis in Children. Salles JM; Bechara C; Tavares AM; Martins M; Sobrinho JG; Dietrich-Neto F; Costa V Braz J Infect Dis; 1999 Apr; 3(2):80-88. PubMed ID: 11098194 [TBL] [Abstract][Full Text] [Related]
15. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Escobedo AA; Alvarez G; González ME; Almirall P; Cañete R; Cimerman S; Ruiz A; Pérez R Ann Trop Med Parasitol; 2008 Apr; 102(3):199-207. PubMed ID: 18348774 [TBL] [Abstract][Full Text] [Related]
16. Plasma disposition, milk excretion and parasitological efficacy of mebendazole in donkeys naturally infected by Cyathostominae. Gokbulut C; Aksit D; Santoro M; Roncoroni C; Mariani U; Buono F; Rufrano D; Fagiolo A; Veneziano V Vet Parasitol; 2016 Feb; 217():95-100. PubMed ID: 26827868 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of single and double doses of albendazole and mebendazole alone and in combination in the treatment of Trichuris trichiura in school-age children in Uganda. Namwanje H; Kabatereine NB; Olsen A Trans R Soc Trop Med Hyg; 2011 Oct; 105(10):586-90. PubMed ID: 21885077 [TBL] [Abstract][Full Text] [Related]
18. Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. Sadjjadi SM; Alborzi AW; Mostovfi H J Trop Pediatr; 2001 Jun; 47(3):176-8. PubMed ID: 11419683 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Silber SA; Diro E; Workneh N; Mekonnen Z; Levecke B; Steinmann P; Umulisa I; Alemu H; Baeten B; Engelen M; Hu P; Friedman A; Baseman A; Mrus J Am J Trop Med Hyg; 2017 Dec; 97(6):1851-1856. PubMed ID: 29016336 [TBL] [Abstract][Full Text] [Related]
20. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]